Author

Catherine Reenaers 1

1 Assistants en formation gastro, réseau Ulg - CHU Sart Tilman, Assistants en formation gastro, réseau Ulg; Lantremange/BE

Clinical case: An IBD patient with fever

Catherine Reenaers, Abraham (Rami) Eliakim

CLINICAL OUTCOME OF PERIANAL CROHN’S DIESEASE AND IMPACT OF TREATMENT STRATEGIES OVER THE TIME

Catherine Reenaers, Alexandre Natalis, Edouard Louis

Combination therapy: Pro

Catherine Reenaers

DEVELOPMENT OF A SMALL BOWEL CAPSULE ENDOSCOPIC INDEX OF SEVERITY IN PATIENTS WITH CROHN’S DISEASE

Arnaud Bourreille, Alain Attar, Vincent Maunoury, Marion Simon, Laurence Picon, Mathurin Fumery, Stéphanie Viennot, Catherine Reenaers, Isabelle Nion Larmurier, Jerome Filippi, Bruno Bonaz, Olivier Dewit, Xavier Dray, Jacques Moreau, Romain Altwegg, Xavier Roblin, Carmen Stefanescu, Jean Yves Mary

IMMUNOSUPPRESSIVE CO-TREATMENT WITH INFLIXIMAB AND ADALIMUMAB IS NOT SUPERIOR TO ANTI-TNF MONOTHERAPY TO PREVENT TREATMENT FAILURE AND TREATMENT DISCONTINUATION IN ULCERATIVE COLITIS.

Catherine Reenaers

IMMUNOSUPPRESSIVE CO-TREATMENT WITH INFLIXIMAB AND ADALIMUMAB IS NOT SUPERIOR TO ANTI-TNF MONOTHERAPY TO PREVENT TREATMENT FAILURE AND TREATMENT DISCONTINUATION IN ULCERATIVE COLITIS.

Sophie Vieujean, Edouard Louis, Catherine Reenaers

LONG-TERM OUTCOME AFTER INFLIXIMAB WITHDRAWAL FOR SUSTAINED REMISSION IN CROHN’S DISEASE

Catherine Reenaers, Maria Nachury, Yoram Bouhnik, David Laharie, Matthieu Allez, Jean-Louis Dupas, Aurelien Amiot, Guillaume Savoye, Romain Altwegg, Georgia Malamut, Arnaud Bourreille, Bernard Flourie, Philippe Marteau, Lucine Vuitton, Benoit Coffin, Stéphanie Viennot, Jean-Frederic Colombel, Jean Yves Mary, Edouard Louis

MRI EVOLUTION AND EFFICACY OF BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN PERIANAL FISTULAE IN CROHN’S DISEASE: RESULTS FROM A PROSPECTIVE MONOCENTRIC STUDY

Catherine Reenaers, Romain Gillard, Carla COIMBRA, Sophie Vieujean, René Gillard, Paul Meunier, Chantal Lechanteur, Etienne Baudoux, Layla Boutaffala, Yves Beguin, Edouard Louis

NATURAL HISTORY OF NON-SEVERE INFLAMMATORY BOWEL DISEASES AT DIAGNOSIS

Cyrielle Pirard, Edouard Louis, Catherine Reenaers

OPEN LABEL OBSERVATIONAL STUDY EVALUATING THE EFFECT OF INDUCTION THERAPY WITH VEDOLIZUMAB IN PATIENTS WITH MODERATE TO SEVERE INFLAMMATORY BOWEL DISEASE INTOLERANT/RESISTANT TO AT LEAST TWO BIOLOGICALS

Martine De Vos, Barbara Dhooghe, Severine Vermeire, Edouard Louis, Mana Fazia, An Elewaut, Peter Bossuyt, Filip Baert, Catherine Reenaers, Marc Van Gossum, Elisabeth Macken, Marc Ferrante, Pieter Hindryckx, Sophie De Wit, Tom Holvoet, Denis Franchimont

Item 1 - 10 / 20
1
2